Breaking News Instant updates and real-time market news.

KEY

KeyCorp

$12.74

-0.02 (-0.16%)

16:15
10/06/16
10/06
16:15
10/06/16
16:15

KeyCorp initiated with an Outperform at Wedbush

Wedbush analyst Peter Winter initiated coverage of KeyCorp with an Outperform rating and $15 price target.

  • 25

    Oct

KEY KeyCorp
$12.74

-0.02 (-0.16%)

07/25/16
07/25/16
INITIATION

On The Fly: Top five analyst initiations
Catch up on today's top five analyst initiations with this list compiled by The Fly: 1. Allergan (AGN) initiated with an Outperform at Credit Suisse. 2. VMware (VMW) initiated with an Overweight at Morgan Stanley. 3. Syros Pharmaceuticals (SYRS) initiated with an Overweight at Piper Jaffray, an Outperform at JMP Securities, an Outperform at Cowen, and an Outperform at Wedbush. 4. Level 3 (LVLT) initiated with a Sector Weight at Pacific Crest. 5. KeyCorp (KEY) reinstated with an Overweight at JPMorgan. This list is just a portion of The Fly's analyst coverage. To see The Fly's full Street Research coverage, click here.
08/29/16
PIPR
08/29/16
DOWNGRADE
Target $13
PIPR
Neutral
KeyCorp downgraded to Neutral from Overweight at Piper Jaffray
Piper Jaffray analyst Kevin Barker downgraded KeyCorp to Neutral saying expectations are too high heading into the "noisy" second half of the year. The analyst lowered his price target for the shares to $13 from $14.50. The shares will have a difficult time outperforming peers as estimates continue to move lower over the next several months, Barker tells investors in a research note.
10/05/16
10/05/16
DOWNGRADE

Equal Weight
Fifth Third downgraded to Equal Weight at Stephens
As previously reported, Stephens analyst Terry McEvoy downgraded Fifth Third (FITB) to Equal Weight from Overweight on valuation. The analyst now sees the underlying value and capital flexibility from the company's investment in Vantiv (VNTV) as being largely reflected in the stock's valuation and have more comfort in future expense trends. Given the outperformance at Fifth Third, McEvoy believes investors should take profits and move into KeyCorp (KEY).
10/06/16
WEDB
10/06/16
INITIATION
WEDB
Outperform
Citizens Financial initiated with an Outperform at Wedbush
Wedbush analyst Peter Winter initiated coverage of 14 regional and Texas banks, starting Citizens Financial (CFG) with an Outperform rating. The other three banks on which Winter assigned an Outperform rating are KeyCorp (KEY), Huntington Bancshares (HBAN) and Regions Financial (RF).

TODAY'S FREE FLY STORIES

TSN

Tyson Foods

$65.39

0.25 (0.38%)

17:05
04/24/17
04/24
17:05
04/24/17
17:05
Hot Stocks
Tyson Foods explores sale of three non-protein businesses »

As part of its strategic…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 08

    May

WHR

Whirlpool

$174.80

3.29 (1.92%)

17:05
04/24/17
04/24
17:05
04/24/17
17:05
Earnings
Whirlpool reports Q1 ongoing EPS $2.50, consensus $2.65 »

Reports Q revenue $4.8B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 04

    May

IBTX

Independent Bank

$63.00

3.1 (5.18%)

17:05
04/24/17
04/24
17:05
04/24/17
17:05
Earnings
Independent Bank reports Q1 core EPS 84c, consensus 81c »

Net interest income was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

CR

Crane

$77.91

1.37 (1.79%)

17:03
04/24/17
04/24
17:03
04/24/17
17:03
Earnings
Crane raises FY17 EPS view to $4.35-$4.55 from $4.30-$4.55, consensus $4.45 »

Max Mitchell, Crane Co.…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

CR

Crane

$77.91

1.37 (1.79%)

17:02
04/24/17
04/24
17:02
04/24/17
17:02
Earnings
Crane reports Q1 EPS $1.05, consensus $1.00 »

Reports Q1 revenue $673M,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 09

    May

MRK

Merck

$62.14

0.25 (0.40%)

, BIIB

Biogen

$276.86

3.92 (1.44%)

17:02
04/24/17
04/24
17:02
04/24/17
17:02
Hot Stocks
FDA clears Remicade biosimilar from Samsung Bioepis »

The FDA has granted…

MRK

Merck

$62.14

0.25 (0.40%)

BIIB

Biogen

$276.86

3.92 (1.44%)

JNJ

Johnson & Johnson

$122.89

1.13 (0.93%)

SSNLF

Samsung

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Apr

  • 25

    Apr

  • 02

    May

  • 03

    May

  • 07

    May

  • 10

    May

  • 27

    May

  • 31

    May

  • 06

    Jun

  • 09

    Jun

  • 14

    Jun

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:01
04/24/17
04/24
17:01
04/24/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Ameriprise »

Ameriprise announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:01
04/24/17
04/24
17:01
04/24/17
17:01
Hot Stocks
Breaking Hot Stocks news story on Ameriprise »

Ameriprise raises…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

AKRX

Akorn

$32.72

-0.19 (-0.58%)

, FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Hot Stocks
Akorn backs FY17 adjusted EPS view $1.53-$1.72, consensus $1.63 »

Backs FY17 revenue view…

AKRX

Akorn

$32.72

-0.19 (-0.58%)

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AMP

Ameriprise

$131.86

3.42 (2.66%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Earnings
Ameriprise reports Q1 operating EPS $2.70, consensus $2.52 »

Reports Q1 revenue $2.9B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

17:00
04/24/17
04/24
17:00
04/24/17
17:00
Hot Stocks
Breaking Hot Stocks news story on Summit Financial Group »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:59
04/24/17
04/24
16:59
04/24/17
16:59
Hot Stocks
Fresenius to acquire Akorn for $34 per share »

Fresenius Kabi (FSNUY)…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:58
04/24/17
04/24
16:58
04/24/17
16:58
Hot Stocks
Breaking Hot Stocks news story on Fresenius SE, Akorn »

Fresenius to acquire…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

, AKRX

Akorn

$32.72

-0.19 (-0.58%)

16:58
04/24/17
04/24
16:58
04/24/17
16:58
Periodicals
Breaking Periodicals news story on Fresenius SE, Akorn »

Fresenius SE to acquire…

FSNUY

Fresenius SE

$20.56

0.89 (4.52%)

AKRX

Akorn

$32.72

-0.19 (-0.58%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:56
04/24/17
04/24
16:56
04/24/17
16:56
Hot Stocks
Wells Fargo: 'Pleased' with Fed, FDIC findings, committed to 'sound resolution' »

Wells Fargo issued the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

OMED

OncoMed

$3.77

0.04 (1.07%)

16:48
04/24/17
04/24
16:48
04/24/17
16:48
Hot Stocks
OncoMed announces workforce reduction »

OncoMed Pharmaceuticals…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 06

    Jun

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Hot Stocks
Express Scripts down 12% after contract with Anthem unlikely to be renewed »

In after hours trading,…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:46
04/24/17
04/24
16:46
04/24/17
16:46
Earnings
Owens-Illinois sees FY17 EPS $2.40-$2.50, consensus $2.43 »

The Company continues to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:45
04/24/17
04/24
16:45
04/24/17
16:45
Hot Stocks
Breaking Hot Stocks news story on Express Scripts »

Express Scripts trading…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 06

    Jun

OI

Owens-Illinois

$21.34

0.83 (4.05%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Earnings
Owens-Illinois reports Q1 EPS 58c, consensus 53c »

Reports Q1 revenue $1.6B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

WFC

Wells Fargo

$53.65

0.65 (1.23%)

16:44
04/24/17
04/24
16:44
04/24/17
16:44
Hot Stocks
Federal Reserve, FDIC approve revised Wells Fargo living will »

The Federal Deposit…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 11

    May

  • 31

    May

  • 13

    Jul

  • 12

    Oct

  • 15

    Jan

ESRX

Express Scripts

$67.25

0.79 (1.19%)

, ANTM

Anthem

$168.41

0.61 (0.36%)

16:43
04/24/17
04/24
16:43
04/24/17
16:43
Hot Stocks
Express Scripts CEO: 'Perplexed' by potential loss of Anthem contract »

Says Anthem deal is…

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 18

    May

  • 06

    Jun

SMMF

Summit Financial Group

$23.00

0.28 (1.23%)

16:41
04/24/17
04/24
16:41
04/24/17
16:41
Hot Stocks
Summit Financial Group announces resolution of litigation »

Summit Financial Group…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CVS

CVS Health

$80.05

0.77 (0.97%)

, ESRX

Express Scripts

$67.25

0.79 (1.19%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Breaking Hot Stocks news story on CVS Health, Express Scripts, Anthem »

CVS up 2% after Express…

CVS

CVS Health

$80.05

0.77 (0.97%)

ESRX

Express Scripts

$67.25

0.79 (1.19%)

ANTM

Anthem

$168.41

0.61 (0.36%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Apr

  • 26

    Apr

  • 02

    May

  • 10

    May

  • 18

    May

  • 06

    Jun

NVS

Novartis

$74.61

1.21 (1.65%)

16:39
04/24/17
04/24
16:39
04/24/17
16:39
Hot Stocks
Novartis expands pact with Amgen to commercialize AMG 334 for migraine »

Novartis (NVS) announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 03

    May

  • 06

    Jun

  • 26

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.